These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35499793)

  • 1. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis.
    Li L; Jiang X; Fu L; Zhang L; Feng Y
    Clin Exp Med; 2023 Jul; 23(3):701-715. PubMed ID: 35499793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.
    Megna M; Patruno C; Bongiorno MR; Gambardella A; Guarneri C; Romita P; Raimondo A; Loconsole F; Fabbrocini G
    Clin Drug Investig; 2022 Jun; 42(6):525-531. PubMed ID: 35633470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
    Snast I; Atzmony L; Braun M; Hodak E; Pavlovsky L
    J Am Acad Dermatol; 2017 Jul; 77(1):88-97.e5. PubMed ID: 28495497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
    Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.
    Chiu HY; Hui RC; Huang YH; Huang RY; Chen KL; Tsai YC; Lai PJ; Wang TS; Tsai TF
    Acta Derm Venereol; 2018 Oct; 98(9):829-834. PubMed ID: 29972221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
    Piaserico S; Messina F; Russo FP
    Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
    Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
    PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies.
    Mustafayev K; Torres H
    Clin Microbiol Infect; 2022 Oct; 28(10):1321-1327. PubMed ID: 35283317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
    Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
    Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study.
    Chiu HY; Chiu YM; Chang Liao NF; Chi CC; Tsai TF; Hsieh CY; Hsieh TY; Lai KL; Chiu TM; Wu NL; Hui RC; Lee CN; Wang TS; Chen PH; Yang CC; Huang YH
    J Am Acad Dermatol; 2021 Aug; 85(2):337-344. PubMed ID: 31821860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
    Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
    Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.
    Sanz-Bueno J; Vanaclocha F; García-Doval I; Torrado R; Carretero G; Daudén E; Patricia Ruiz-Genao D; Alsina-Gibert MM; Pérez-Zafrilla B; Pérez-Rial G; Rivera R;
    Actas Dermosifiliogr; 2015; 106(6):477-82. PubMed ID: 25776200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
    Ding ZN; Meng GX; Xue JS; Yan LJ; Liu H; Yan YC; Chen ZQ; Hong JG; Wang DX; Dong ZR; Li T
    J Cancer Res Clin Oncol; 2023 May; 149(5):1993-2008. PubMed ID: 35767193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.
    El Kassas M; Shimakawa Y; Ali-Eldin Z; Funk AL; Wifi MN; Zaky S; El-Raey F; Esmat G; Fontanet A
    Liver Int; 2018 Dec; 38(12):2159-2169. PubMed ID: 29738637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of biologic agents for psoriasis in patients with viral hepatitis.
    AlMutairi N; Abouzaid HA
    J Dermatolog Treat; 2018 Sep; 29(6):553-556. PubMed ID: 29345515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV).
    Pisaturo M; Macera M; Alessio L; Calò F; Coppola N
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis.
    Wang X; Zhang M; Chen Y; Liu Y; Yu Y; Huang X; Gao Y
    Dermatol Ther (Heidelb); 2022 Mar; 12(3):655-670. PubMed ID: 35094295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.